Effect of protracted high-dose L-asparaginase given as a second exposure in a Berlin-Frankfurt-Münster-based treatment: results of the randomized 9102 intermediate-risk childhood acute lymphoblastic leukemia study--a report from the Associazione Italiana Ematologia Oncologia Pediatrica.
作者:
主题词
青少年(Adolescent);抗肿瘤药(Antineoplastic Agents);抗肿瘤联合化疗方案(Antineoplastic Combined Chemotherapy Protocols);天冬酰胺酶(Asparaginase);儿童(Child);儿童, 学龄前(Child, Preschool);无病生存(Disease-Free Survival);女(雌)性(Female);人类(Humans);婴儿(Infant);婴儿, 新生(Infant, Newborn);注射, 肌肉内(Injections, Intramuscular);男(雄)性(Male);前体细胞淋巴母细胞白血病淋巴瘤(Precursor Cell Lymphoblastic Leukemia-Lymphoma);治疗结果(Treatment Outcome)
DOI
10.1200/JCO.2001.19.5.1297
PMID
11230471
发布时间
2017-02-10
- 浏览64

Journal of clinical oncology
1297-303页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文